Login / Signup

Prevalence and differences in the co-administration of drugs known to interact: an analysis of three distinct and large populations.

Jon Sánchez-ValleRion Brattig CorreiaMarta Camacho-ArtachoRosalba LeporeMauro M MattosLuis M RochaAlfonso Valencia
Published in: BMC medicine (2024)
DDI administration has a high incidence in society, regardless of geographic, population, and healthcare management differences. Although DDI prevalence increases with age, our analysis points to a complex phenomenon that is much more prevalent than expected, suggesting comorbidities as key drivers of the increase. Furthermore, the gender differences observed in most age groups across populations are concerning in regard to gender equity in healthcare. Finally, our study exemplifies how electronic health records' analysis can lead to actionable interventions that significantly reduce the administration of known DDI and its associated human and economic costs.
Keyphrases
  • healthcare
  • electronic health record
  • risk factors
  • endothelial cells
  • physical activity
  • induced pluripotent stem cells